FOSTER & MOTLEY INC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1163902 CINCINNATI, OH

Position in HALO

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,995,963

+$441,612 QoQ

Shares Held

25,501

+6.0% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#242

of 661 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FOSTER & MOTLEY INC holds $3,006,943 across 4 Biotechnology names. HALO ranks #1 (66.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	25,501	$1,995,963
2	HRMY	Harmony Biosciences Holdings, Inc.	18,867	$686,947
3	VRTX	Vertex Pharmaceuticals Inc / Ma	414	$205,646
4	SPRY	ARS Pharmaceuticals, Inc.	14,780	$118,387

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,995,963	25,501	+6.0%	Shares	Sole	2026-08-07
2026-03-31	$1,554,351	24,050	+5.3%	Shares	Sole	2026-04-21
2025-12-31	$1,536,593	22,832	-1.6%	Shares	Sole	2026-01-15
2025-09-30	$1,702,148	23,209	-1.4%	Shares	Sole	2025-10-23
2025-06-30	$1,223,978	23,529	-1.6%	Shares	Sole	2025-07-29
2025-03-31	$1,525,441	23,906	+2.7%	Shares	Sole	2025-05-08
2024-12-31	$1,113,016	23,280	+118.6%	Shares	Sole	2025-01-23
2024-09-30	$609,606	10,650	—	Shares	Sole	2024-10-30
No filing history on record for this holder in this stock.